Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-02-01 Sale |
2024-02-02 9:25 pm |
Atea Pharmaceuticals Inc. | AVIR | Vavricka John Chief Commercial Officer |
11,819 | $3.843 | $45,420 | 303,489 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-31 Option Award |
2025-02-04 6:00 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Vavricka John Chief Commercial Officer |
141,550 | $0 | 309,472 (Direct) |
View |
| 2025-01-31 Exercise |
2025-02-04 6:00 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Vavricka John Chief Commercial Officer |
33,333 | $0 | 309,472 (Direct) |
View |
| 2025-01-31 Tax Withholding |
2025-02-04 6:00 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Vavricka John Chief Commercial Officer |
11,517 | $3.06 | 309,472 (Direct) |
View |
| 2024-01-31 Option Award |
2024-02-02 9:25 pm |
N/A 2034-01-30 |
Atea Pharmaceuticals Inc. | AVIR | Vavricka John Chief Commercial Officer |
132,800 | $0 | 303,489 (Direct) |
View |
| 2024-01-31 Exercise |
2024-02-02 9:25 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Vavricka John Chief Commercial Officer |
33,334 | $0 | 303,489 (Direct) |
View |
| 2023-01-31 Option Award |
2023-02-02 6:26 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Vavricka John Chief Commercial Officer |
240,000 | $0 | 240,000 (Direct) |
View |
| 2022-01-31 Option Award |
2022-02-02 5:15 pm |
N/A 2032-01-30 |
Atea Pharmaceuticals Inc. | AVIR | Vavricka John Chief Commercial Officer |
135,000 | $0 | 135,000 (Direct) |
View |
| 2021-01-29 Option Award |
2021-02-01 4:51 pm |
N/A 2031-01-28 |
Atea Pharmaceuticals Inc. | AVIR | Vavricka John Chief Commercial Officer |
117,300 | $0 | 117,300 (Direct) |
View |
| 2020-11-03 Conversion |
2020-11-03 8:04 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Vavricka John Chief Commercial Officer |
82,508 | $0 | 82,508 (Indirect) |
View |
Ownership |
2020-10-29 8:50 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Vavricka John Chief Commercial Officer |
0 | $0 | 472,508 (Indirect) |
View |